The global antifungal drugs market, valued at USD 16.31 billion in 2024, is projected to witness moderate yet consistent growth over the next decade. According to recent industry analysis, the market is forecast to reach USD 23.22 billion by 2034, expanding at a CAGR of 3.6% from 2025 to 2034. The increasing prevalence of fungal infections, growing demand...